Real-world case study webinar demonstrates how AI-powered site identification and automated feasibility outreach delivered 330% more qualified oncology sites in under one month LAGUNA BEACH, Calif., ...

During this session, the panelists discussed the role that SMOs and dedicated clinical trial sites (Site Platforms) play within the life sciences industry, what makes them attractive to investors, and ...

Shuttle Pharmaceuticals (SHPH) Holdings announced it has finalized agreements with all six of the planned site enrollment locations to administer the Phase 2 clinical trial of Ropidoxuridine for the ...

GAITHERSBURG, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on ...

Suvoda has introduced new split budget functionality to its clinical trial software, Budgeting & Benchmarking, supporting sponsors and contract research organisations (CROs) in managing complex, multi ...

Clinical trial sites for cancer are proliferating, but a lack of investigators with experience in trial recruitment is weighing on their performance, according to a report released May 23 by trial ...

NKGen Biotech activates two new clinical trial sites for Alzheimer's treatment, enhancing patient access and recruitment for troculeucel therapy. NKGen Biotech, Inc. has announced the activation of ...

The Phase IIa trial is a randomized, placebo-controlled study evaluating the safety, tolerability, and preliminary clinical signals of ONP-002 in patients presenting with acute concussion and mild ...

NEW YORK, Aug 14 (Reuters) - Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical trial sites, from KKR (KKR.N), opens new tab, ...

Decentralized clinical trials (DCTs) are clinical studies that take place outside of a traditional clinical trial site. They are also known as direct-to-participant trials or virtual studies. DCTs may ...

GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on ...